Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
Estimates Miss
|
Expensive Performer
6033.0000
-98.50
(
-1.61
%)
NSE
Aug 08, 2025
11:26 AM
30.71% Gain from 52W Low
Volume:
157.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
09 Feb 2016
Estimates Miss
6033.00
-1.61%
Divi's Laboratories
Buy:
Divi's Laboratories Ltd.
by
ICICI Securities Limited
Target: 1320
Target
ICICI Securities Limited
Divi's Laboratories Ltd. is trading below all available SMAs
More from Divi's Laboratories Ltd.
Recommended
Market trades lower, Global Health's Q1FY26 net profit surges 49.6% YoY to Rs 159 crore
Trendlyne Marketwatch |
08 Aug 2025, 11:25AM
Chart of the Week: Mutual funds and FIIs bet big on 11 Nifty 500 stocks in Q1FY26
The Baseline |
07 Aug 2025, 05:53PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022